Vibrato device for removing blood clots in sudden pulmonary embolism
Tests a suction device to remove lung clots in adults with acute pulmonary embolism.
Key facts
- Who runs it
- Vicora, Inc.
- Where
- Poland2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Vibrato Aspiration System - Simple, Intuitive Approach to Clot Removal in Acute Pulmonary Embolism - a Safety & Feasibility Study
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 21 Aug 2026
- Expected to end
- Dec 2026
- Type of study
- Interventional
- Treatments tested
- Mechanical Thrombectomy
- Record updated
- 25 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a sudden blood clot in the lungs (acute pulmonary embolism). It tests the Vibrato Aspiration System, a device that sucks the clot out.
- Age
- 18 to 75 years
- Sex
- All sexes
- Disease stage
- Acute PE with symptoms for 14 days or less. A CT scan (CTA) shows a clot in at least one main or interlobar lung artery. The heart's right side is strained (RV/LV ratio of 0.9 or more). Blood pressure (systolic) is 90 mmHg or more, and heart rate is steady below 130 BPM. Doctors judge the person fit enough for the procedure.
- Earlier treatment
- No clot-dissolving drugs (thrombolytics) within 30 days before the baseline CT scan.
- Biomarker or test result
- RV/LV ratio of 0.9 or more on CTA.
Main reasons for not taking part
- Needing blood pressure drugs, a breathing tube, or a lot of oxygen (FiO2 over 40% or over 6 LPM)
- Severe high blood pressure in the lungs, CTEPH or CTED, or severe heart failure
- Bleeding problems, low blood counts (hematocrit below 28%, platelets below 100,000/ML), or heparin cannot be given
- Stroke or TIA in the last 90 days, or cancer needing chemotherapy
- Pregnant or breastfeeding
The registry criteria, word for word
Show all 41 criteriaShow less
Who can take part
- Subjects must meet all following general inclusion criteria:
- Age ≥ 18 and ≤ 75 years
- Clinical signs, symptoms, and presentation consistent with acute PE
- PE symptom duration ≤ 14 days
- CTA evidence (site determined) of proximal PE (filling defect in at least one main or interlobar pulmonary artery)
- RV/LV ratio of ≥ 0.9 on CTA as assessed by investigator (site determined)
- Systolic blood pressure ≥ 90 mmHg
- Stable heart rate < 130 BPM prior to procedure
- Patient is deemed medically eligible for interventional procedure(s), per institutional guidelines and clinical judgment
- Informed Consent Form signed
- Subject is willing and able to comply with all Clinical Investigation Plan required follow-up visit
Who cannot take part
- Cardiovascular or pulmonary surgery within last 7 days
- Known anaphylactic reaction to radiographic contrast agents that cannot be pretreated
- Current participation in another investigational drug or device treatment study
- Pulmonary hypertension with peak pulmonary artery pressure > 70 mmHg by right heart catheterization (site determined)
- Actively progressing cancer requiring chemotherapy
- Known bleeding diathesis or coagulation disorder
- History of severe or chronic pulmonary arterial hypertension
- History of uncompensated heart failure
- History of underlying lung disease that is oxygen dependent
- History of chest irradiation
- History of heparin-induced thrombocytopenia (HIT)
- History of Hemorrhagic or Ischemic Stroke, including Transient Ischemic Attack, within last 90 days
- Current or history of chronic thromboembolic pulmonary hypertension (CTEPH) or chronic thromboembolic disease (CTED) diagnosis
- Platelets < 100,000/ML
- Serum creatinine > 1.8 mg/dL
- International normalized ratio (INR) > 3
- History of chronic left heart disease with left ventricular ejection fraction ≤ 30%
- Subjects must not meet any of the following general exclusion criteria:
- Thrombolytic use within 30 days of baseline CT angiogram
- Vasopressor requirement after fluids to keep pressure ≥ 90 mmHg
- FiO2 requirement > 40% or > 6 LPM to keep oxygen saturation > 90%
- Hematocrit < 28%
- Major trauma injury severity score (ISS) > 15 within the past 14 days
- Presence of intracardiac lead in the right ventricle or right atrium placed within 6 months, Pacemaker or Implantable Cardioverter Defibrillators
- Left bundle branch block
- Patients who are under intubation
- Any contraindication to systemic or therapeutic doses of heparin or anticoagulants
- Imaging evidence or other evidence that suggests, in the opinion of the Investigator, the Subject is not appropriate for mechanical thrombectomy intervention
- Life expectancy of < 90 days, as determined by Investigator
- Female who is pregnant or nursing
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in Poland.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vibrato™ Aspiration System for aspiration mechanical thrombectomy in the treatment of acute PE. This is the First in Man clinical study.
The group in the trial
- Single arm studyTreatment being tested
Vibrato™ Aspiration System for aspiration mechanical thrombectomy in the treatment of acute pulmonary embolism.
Treatment: Mechanical Thrombectomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Vibrato Aspiration System - Simple, Intuitive Approach to Clot Removal in Acute Pulmonary Embolism - a Safety & Feasibility Study
- Plain-language title
- Vibrato device for removing blood clots in sudden pulmonary embolismGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07685522, who can take part
- Record updated
- 25 August 2026